TDC
SZYM

Thompson Davis & Co’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Thompson Davis & Co’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-250
Closed -$3K – 940
2014
Q1 		$3K Buy
+250
New +$2.94K 0.01% 734

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Thompson Davis & Co's SZYM Position: Q2 2014 in Review

Thompson Davis & Co sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2014, closing a stake of 250 shares — an estimated $3K sold.

Thompson Davis & Co first reported a position in SZYM in Q1 2014 and held it in 1 quarter. The position peaked at $3K in Q1 2014. 124 funds tracked by Wall St. Rank hold SZYM as of Q2 2014.

  • Thompson Davis & Co reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • Thompson Davis & Co sold 250 SOLAZYME INC COM STK (DE) shares in Q2 2014, an estimated $3K.
  • Thompson Davis & Co first reported a position in SOLAZYME INC COM STK (DE) in Q1 2014 and held it in 1 quarter.
  • Thompson Davis & Co's SOLAZYME INC COM STK (DE) position peaked at $3K in Q1 2014.
  • 124 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2014.

Based on Thompson Davis & Co's 13F filing for Q2 2014, filed 12 Aug 2014.